About MDS Pharma Services
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MDS Pharma Services
During the past decade, MDS Pharma Services conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
Completed
240
A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
1997-10-01
1999-03-01
Completed
20
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
2000-05-19
2010-01-27
Completed
3,436
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
2001-08-01
Completed
52
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
2001-10-18
Active, not recruiting
1,449
Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
1997-12-01
2008-04-01
Completed
46
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MDS Pharma Services" #1 sponsor was "GlaxoSmithKline" with 4 trials, followed by "Actavis Inc." with 2 trials
sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Global Alliance for TB Drug Development"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MDS Pharma Services"
#1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator and "Halozyme Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at MDS Pharma Services
According to Clinical.Site data, the most researched conditions in "MDS Pharma Services" are
"Healthy" (8 trials), "Healthy Subjects" (5 trials), "Nausea" (2 trials), "Tuberculosis" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "MDS Pharma Services" in a lesser frequency.
Clinical Trials Intervention Types at MDS Pharma Services
Most popular intervention types in "MDS Pharma Services" are "Drug" (20 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Experimental paracetamol formulation" (3 trials), "Marketed paracetamol" (3 trials), "APD791" (2 trials), "Granisetron" (2 trials) and "Avinza (morphine sulfate sustained-release) capsules" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MDS Pharma Services
The vast majority of trials in "MDS Pharma Services" are
19 trials for "All" genders and 4 trials for "Male" genders.
Clinical Trials Status at MDS Pharma Services
Currently, there are NaN active trials in "MDS Pharma Services".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 23 completed trials in MDS Pharma Services,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MDS Pharma Services, 18 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 3 trials that are defined as “Not Applicable".